The delivery beat provided much needed tailwinds for the company after a first quarter that saw price cuts , layoffs and a recall that gave investors their first glimpse into the sales of the Cybertruck and a second quarter that was dominated by questions around CEO Elon Musk's compensation package .
Tesla announced that its second quarter earnings will be released after market close on July 19 with its earnings call set for 5:30 ET the same day.
Analysts bullish after Tesla delivery beat
A Tesla logo is seen the buildings of a future dealership located in Tallahassee, Florida on Monday, July 1, 2024. Alicia Devine/Tallahassee Democrat / USA TODAY NETWORK
Some business analysts were buoyed by the delivery beat with Wedbush Analytics raising their price target for the stock and saying the report was a "major turning point."
"With the majority of price cuts in the rear-view mirror and demand stabilization globally for EVs especially in China, we believe Tesla's march towards 2 million units annual trajectory should be reached over the coming quarters with clear momentum and easier comps for 2025," Wedbush said.
Tesla stock bounces on beat
Tesla's shares rallied Tuesday closing up 10% at $231.26 per share, continuing a rally that began in June.
Get updates delivered to you daily. Free and customizable.
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. We strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation. Join us in shaping the news narrative together.
Comments / 0